XML 51 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-based Compensation - Additional Information (Detail)
$ in Millions
9 Months Ended
Apr. 10, 2015
shares
Oct. 30, 2013
shares
Sep. 30, 2016
USD ($)
plan
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options outstanding, weighted average remaining contractual life (in years)     7 years 7 months 6 days
Number of equity compensation plans | plan     2
Additional awards granted (shares)     783,936
2005 Aerie Pharmaceutical stock plan and 2013 omnibus incentive plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation expense | $     $ 26.1
Compensation cost, weighted average recognition period (in years)     2 years 3 months 18 days
Options outstanding, weighted average remaining contractual life (in years)     7 years 7 months 6 days
2005 Aerie Pharmaceutical Stock Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Additional awards granted (shares)   0  
2013 Omnibus incentive plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Additional awards granted (shares) 0    
Equity awards (up to) (shares)     5,729,068
Restricted stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation expense | $     $ 2.6
Restricted stock awards, weighted average remaining contractual term (in years)     2 years 9 months 18 days
Restricted stock | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based awards, vesting period (in years)     1 year
Restricted stock | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based awards, vesting period (in years)     4 years